Shanghai Hile Bio-Technology Co., Ltd. (603718.SS)
CNY 7.45
(0.0%)
CNY 7.45
(0.0%)
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2023 | 102.82 Million CNY | -29.03% |
| 2022 | 144.88 Million CNY | 1.59% |
| 2021 | 142.62 Million CNY | 23.0% |
| 2020 | 115.94 Million CNY | 1.94% |
| 2019 | 113.74 Million CNY | -11.66% |
| 2018 | 128.75 Million CNY | 29.23% |
| 2017 | 99.63 Million CNY | 148.13% |
| 2016 | 40.15 Million CNY | 17.8% |
| 2015 | 34.08 Million CNY | -6.36% |
| 2014 | 36.4 Million CNY | 33.6% |
| 2013 | 27.24 Million CNY | -5.97% |
| 2012 | 28.97 Million CNY | 18.18% |
| 2011 | 24.51 Million CNY | 0.0% |
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2024 Q3 | 84.78 Million CNY | -17.53% |
| 2024 Q1 | 93.04 Million CNY | -9.51% |
| 2024 Q2 | 102.8 Million CNY | 10.49% |
| 2023 Q3 | 94.88 Million CNY | -20.52% |
| 2023 Q2 | 119.38 Million CNY | -22.93% |
| 2023 FY | 102.82 Million CNY | -29.03% |
| 2023 Q4 | 102.82 Million CNY | 8.36% |
| 2023 Q1 | 154.89 Million CNY | 6.91% |
| 2022 Q4 | 144.88 Million CNY | 9.78% |
| 2022 Q3 | 131.98 Million CNY | -7.85% |
| 2022 Q1 | 137.56 Million CNY | -3.55% |
| 2022 FY | 144.88 Million CNY | 1.59% |
| 2022 Q2 | 143.22 Million CNY | 4.12% |
| 2021 Q2 | 129.74 Million CNY | 15.56% |
| 2021 Q4 | 142.62 Million CNY | 14.43% |
| 2021 FY | 142.62 Million CNY | 23.0% |
| 2021 Q1 | 112.27 Million CNY | -3.17% |
| 2021 Q3 | 124.63 Million CNY | -3.94% |
| 2020 Q1 | 110.87 Million CNY | -2.52% |
| 2020 Q2 | 98.86 Million CNY | -10.83% |
| 2020 Q4 | 115.94 Million CNY | 20.38% |
| 2020 FY | 115.94 Million CNY | 1.94% |
| 2020 Q3 | 96.31 Million CNY | -2.58% |
| 2019 Q3 | 108.31 Million CNY | -12.24% |
| 2019 FY | 113.74 Million CNY | -11.66% |
| 2019 Q4 | 113.74 Million CNY | 5.02% |
| 2019 Q1 | 115.9 Million CNY | -9.98% |
| 2019 Q2 | 123.41 Million CNY | 6.48% |
| 2018 Q1 | 103.1 Million CNY | 3.48% |
| 2018 FY | 128.75 Million CNY | 29.23% |
| 2018 Q4 | 128.75 Million CNY | -12.19% |
| 2018 Q3 | 146.63 Million CNY | 2.12% |
| 2018 Q2 | 143.59 Million CNY | 39.27% |
| 2017 Q4 | 99.63 Million CNY | 15.76% |
| 2017 FY | 99.63 Million CNY | 148.13% |
| 2017 Q1 | 44.84 Million CNY | 11.68% |
| 2017 Q2 | 64.23 Million CNY | 43.24% |
| 2017 Q3 | 86.07 Million CNY | 33.99% |
| 2016 Q4 | 40.15 Million CNY | 2.67% |
| 2016 Q2 | 39.57 Million CNY | 8.09% |
| 2016 Q1 | 36.61 Million CNY | 7.42% |
| 2016 Q3 | 39.11 Million CNY | -1.18% |
| 2016 FY | 40.15 Million CNY | 17.8% |
| 2015 Q3 | 33.48 Million CNY | -0.59% |
| 2015 Q1 | 38.76 Million CNY | 6.49% |
| 2015 FY | 34.08 Million CNY | -6.36% |
| 2015 Q4 | 34.08 Million CNY | 1.8% |
| 2015 Q2 | 33.68 Million CNY | -13.11% |
| 2014 FY | 36.4 Million CNY | 33.6% |
| 2014 Q1 | - CNY | 0.0% |
| 2014 Q4 | 36.4 Million CNY | 0.0% |
| 2013 FY | 27.24 Million CNY | -5.97% |
| 2012 FY | 28.97 Million CNY | 18.18% |
| 2011 FY | 24.51 Million CNY | 0.0% |